These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5649161)

  • 1. Studies on cross-resistance to degranol- and dibromodulcitol-resistant Yoshida tumours.
    Gáti E
    Int J Cancer; 1968 Mar; 3(2):260-4. PubMed ID: 5649161
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations on the mechanism of action of cytotoxic hexitols. I. Cross-resistance investigations on Yoshida sarcoma tumour.
    Jeney A; Szabó J; Vályi-Nagy T
    Neoplasma; 1968; 15(3):231-5. PubMed ID: 5667085
    [No Abstract]   [Full Text] [Related]  

  • 3. A new antitumour agent: phenazathionium-mustard salt.
    Csaba G; Körösi J
    Neoplasma; 1968; 15(4):443-5. PubMed ID: 5684468
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytochemical characterization of Yoshida sarcoma cells resistant to dibromodulcitol.
    Gáti E; Pokorny E; Somfai-Relle S; Szentirmay Z
    Int J Tissue React; 1984; 6(1):43-51. PubMed ID: 6715118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NITROGEN MUSTARD-RESISTANT YOSHIDA SARCOMA AND CROSS-RESISTANCE STUDIES.
    UJHAZY V; WINKLER A
    Neoplasma; 1965; 12():11-4. PubMed ID: 14278323
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromosomal analysis on Yoshida tumor cells sensitive and resistant to dibromodulcitol.
    Gáti E
    Neoplasma; 1979; 26(1):79-83. PubMed ID: 431758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.
    Csányi E; Halász M
    Br J Cancer; 1967 Jun; 21(2):353-7. PubMed ID: 6028086
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 9. The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma.
    Miko M; Ujházy V
    Neoplasma; 1968; 15(4):357-63. PubMed ID: 5684461
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation on the mode of action of cytotoxic hexitols V. Pharmaco-biochemical studies with dibromomannitol.
    Szabŏ J; Jeney A; Darŏcy A; Institoris L; Nosztray K; Vályi-Nagy T
    Neoplasma; 1973; 20(1):13-25. PubMed ID: 4702202
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and characterization of nitrogen mustard-sensitive cells from a nitrogen mustard-resistant subline of Yoshida sarcoma.
    Isaka H; Izumitani M; Moriwaki A; Sakurai Y
    Gan; 1966 Aug; 57(4):353-66. PubMed ID: 5969489
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor effectiveness of improsulfan on nitrogen mustard-resistant Yoshida sarcoma cells.
    Okumoto T; Sugimoto N; Imamura H
    Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):3003-8. PubMed ID: 203408
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro-in vivo studies on the susceptibility of the solid Yoshida sarcoma to drugs and hyperthermia (42 degrees).
    Dickson JA; Suzangar M
    Cancer Res; 1974 Jun; 34(6):1263-74. PubMed ID: 4363651
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlation of the differences of biological effects and distribution parameters of 1,6-dibromohexitols].
    Institóris L; Dzurillay E; Sebestyén JH; Jeney A; Pethes G
    Z Krebsforsch; 1971; 75(2):133-45. PubMed ID: 4256522
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of nitrogen-mustard sensitive and -resistant Yoshida sarcomas.
    Ball CR; Connors TA; Double JA; Ujhazy V; Whisson ME
    Int J Cancer; 1966 Jul; 1(4):319-27. PubMed ID: 5911173
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromosomal studies with the nitrogen mustard-sensitive and resistant Yoshida tumour.
    Ujházy V
    Neoplasma; 1968; 15(6):657-61. PubMed ID: 5704185
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
    Veselá H; Jelínek V; Pujman V; Zlatkovská Z
    Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of nitrogen mustard sensitive and resistant Yoshida sarcomas. II. Effect of treatment on cell kinetics.
    Ball CR; Connors TA; Cooper EH; Topping NE
    Neoplasma; 1967; 14(3):253-64. PubMed ID: 6063004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Strain of Yoshida sarcoma with induced pafencil resistance].
    Khomchenovskiĭ EI; Burova GF
    Biull Eksp Biol Med; 1985 Apr; 99(4):479-81. PubMed ID: 3986376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identical karyotypes in acquired drug-resistant sublines of Yoshida sarcoma.
    Ujhåzy V
    Neoplasma; 1974; 21(6):665-9. PubMed ID: 4444746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.